HIND Stock Forecast - ReShape Lifesciences Inc

	ReShape Lifesciences Inc NASDAQ:HIND	US
L	LBC Express Holdings Inc XPHS:LBC	PH
G	Gladiator Metals Corp OTC:GDTRF	CA
	Advance Energy PLC F:BZP	UK
P	Public Property Invest ASA OSE:PUBLI	NO
	St James Gold Corp F:BVU3	CA
	Countplus Ltd ASX:CUP	AU
	Prophase Labs Inc OTC:PRPH	US
	Cardiex Ltd ASX:CDX	AU

Wall St Price Targets

Wall Street analysts forecast HIND stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HIND is 11.73 USD with a low forecast of 8.08 USD and a high forecast of 15.75 USD.

HIND Lowest Forecast

274% Upside

HIND Average Forecast

443% Upside

HIND Highest Forecast

629% Upside

274% Upside

443% Upside

629% Upside

Fox Corp

4% Upside

F

Festi hf

-69% Downside

Fox Corp

4% Upside

F

Festi hf

-69% Downside

Revenue
Forecast

8% / Year

Past Growth

53% / Year

Estimated Growth

Estimates Accuracy

-3%

Average Miss

8% / Year

Past Growth

53% / Year

Estimated Growth

Estimates Accuracy

-3%

Average Miss

Over the last 9 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 1 year is 53%.

What are analyst estimates?

Gross Profit
Forecast

14% / Year

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

14% / Year

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

Operating Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

1%

Average Beat

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

1%

Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

Net Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-100%

Average Miss

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-100%

Average Miss

What are analyst estimates?

Continue HIND Research

Summary

DCF Valuation

Relative Valuation

Wall St Estimates

Profitability

Solvency

Financials

Discount Rate

NASDAQ • USD

RSLS

F • EUR

24O0

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

According to Wall Street analysts, the average 1-year price target for HIND is 11.73 USD with a low forecast of 8.08 USD and a high forecast of 15.75 USD.

Over the last 9 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 1 year is 53%.

Back to Top

ReShape Lifesciences Inc
NASDAQ:HIND

Wall St Price Targets

HIND Price Targets Summary
ReShape Lifesciences Inc

Revenue
Forecast

Gross Profit
Forecast

Operating Income
Forecast

Pre-Tax Income
Forecast

Net Income
Forecast

Continue HIND Research

What is HIND's stock price target?

Price Target
11.73 USD

What is the Revenue forecast for ReShape Lifesciences Inc?

Projected CAGR
53%

Company

Help

Tools

Stocks

ReShape Lifesciences Inc NASDAQ:HIND

Wall St Price Targets

HIND Price Targets Summary ReShape Lifesciences Inc

Revenue Forecast

Gross Profit Forecast

Operating Income Forecast

Pre-Tax Income Forecast

Net Income Forecast

Continue HIND Research

What is HIND's stock price target? Price Target 11.73 USD

What is the Revenue forecast for ReShape Lifesciences Inc? Projected CAGR 53%

Company

Help

Tools

Stocks

ReShape Lifesciences Inc
NASDAQ:HIND

HIND Price Targets Summary
ReShape Lifesciences Inc

Revenue
Forecast

Gross Profit
Forecast

Operating Income
Forecast

Pre-Tax Income
Forecast

Net Income
Forecast

What is HIND's stock price target?

Price Target
11.73 USD

What is the Revenue forecast for ReShape Lifesciences Inc?

Projected CAGR
53%